Patents by Inventor Tadashi NAMISAKI

Tadashi NAMISAKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medicine obtained by combining FXR agonist and ARB
    Patent number: 11419878
    Abstract: The present invention provides an NASH therapeutic agent including: an FXR agonist, preferably obeticholic acid or a pharmaceutically acceptable salt thereof; and an ARB or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: August 23, 2022
    Assignee: Intercept Pharmaceuticals, Inc.
    Inventors: Tadashi Namisaki, Hitoshi Yoshiji
  • Medicine Obtained by Combining FXR Agonist and ARB
    Publication number: 20190247404
    Abstract: The present invention provides an NASH therapeutic agent including: an FXR agonist, preferably obeticholic acid or a pharmaceutically acceptable salt thereof; and an ARB or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 27, 2017
    Publication date: August 15, 2019
    Inventors: Tadashi NAMISAKI, Hitoshi YOSHIJI